Tech Company Financing Transactions
XORI Funding Round
On 6/30/2010, XORI received $2.3 million in funding from Arch Venture Partners, OVP Venture Partners and private investors.
Transaction Overview
Company Name
Announced On
6/30/2010
Transaction Type
Venture Equity
Amount
$2,300,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1616 Eastlake Ave. E 200
Seattle, WA 98102
USA
Seattle, WA 98102
USA
Phone
Website
Email Address
Overview
XORI (chore-ee) is focused on a unique technology for the rapid discovery and development of monoclonal antibodies (MAbs).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Thong Le
Chief Financial Officer
Lindsay Rayle
Chief Operating Officer
David Schubert
Chief Scientific Officer
David McElligott
Browse more venture capital transactions:
Prev: 6/30/2010: ATRP Solutions venture capital transaction
Next: 6/30/2010: CerviLenz venture capital transaction
Share this article
Where The Data Comes From
We document every notable VC transaction. VC transactions reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs